In 2025, Kuiyuan Zhang and a team from Guizhou University of Traditional Chinese Medicine analyzed data from public databases to study how artificial sweeteners like aspartame, sucralose, and saccharin relate to prostate cancer. They used computer models and lab tests to find key genes and see how sweeteners interact with cancer cells.

In 2025, S. Fattahi and a team studied men with prostate cancer in a randomized cohort, followed over time. They analyzed testosterone levels at diagnosis, adjusting for age, cancer stage, and treatments like hormone therapy, to check links with cancer severity and death rates.